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We read with great interest the article by Sonoda et al published on line (Gut 
doi:10.1136/gut.2010.218305) of canine scent detection in those with colorectal cancer. The 
concept of using a dog to detect diseases is not new; there are many reported incidents of 
dogs barking at their owners (or even trying to bite the leg off of an owner with melanoma!) 
who are later shown to have the disease. 
Several studies have shown that dogs are able to detect, amongst others, breath, lung, bladder, 
ovary, prostate and skin cancers. In these reports the dog is trained to recognise the disease 
state (in fact the dog is reminded of these different groups usually the morning of the 
experiment). It is also important to recognise that the dog achieves this separation even 
within the ‘multi-odour’ hospital environment, unlike modern sophisticated instrumentation 
such as GC/MS. An important part of this work is the relationship between the handler and 
the dog, but, a notable question is why the handler (or doctor) is not sniffing the sample 
themselves? Though the dog out performs humans in terms of chemical detection limit and 
sensitivity, the human nose is still a power ‘sniffing’ tool. Dogs have ~ 200 million olfactory 
receptors (or more than 800 different types) with up to 6% of their genome devoted to 
olfactory receptors (1) compared with humans ~ 5 million and up to 2% of the genome – 
where olfactory receptors are still the largest single family within the human genome (2).  
If we consider the history of medicine, it is only recently that “sniffing” or even tasting 
bodily output of a patient has fallen into miss-use. There are reports that the ancient Chinese 
used sniffing as part of the diagnosis process. In medieval times, doctors believed that the 
colour, smell and taste of a patient’s urine was important (for example sweetness to identify 
diabetes). In Victorian times, medical training included instructions to students on how to 
interpret the sights, sounds, feel and even smell of disease. Even today, through discussions 
with nurses, they are able to identify disease through smell (e.g. Clostridium Difficille), well 
before microbiology toxin results are available. One limitation of course is that dogs like 
humans undergo ‘olfaction fatigue’ where olfactory receptors become saturated with a 
particular odour hence sensitivity is lost with continuous exposure.  
Thus perhaps an alternative modern approach is required encompassing robotic olfaction. The 
“Electronic Nose” is an attempt to create such technology. It is an instrument that attempts to 
replicate the human olfactory system. Here, arrays (normally 32 or less) of chemical sensors 
are used with each sensor being in some way different. Thus, the interaction between the 
sample and the sensor is unique for every sensor. This generates a pattern of responses that is 
described as the “smell fingerprint” of a sample. A model is then built that learns these 
fingerprints and when exposed once more they recognise and identify the smell. Medical 
Olfactory systems have been adapted for detection of lung cancer, schizophrenia and wound 
infections (3). Similarly, we have shown its utility to distinguish between gastrointestinal and 
metabolic disease groups (4) – all based on profiling volatile organic compounds (VOCs). 
Thus the technology is available and has practical clinical utility. Should we therefore replace 
mammalian scent detection with a machine or return to teaching physicians to sniff? 
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